Vizsgálati helyszín
Banner McKee Medical Center
Loveland, Colorado 80539, Egyesült ÁllamokMég nincs intézményhez kötve
- 3futó vizsgálat
- 15lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 18 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 2. fázis6 vizsgálat
- 3. fázis6 vizsgálat
- 2/3. fázis4 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Lezárult14 vizsgálat
- Fut, nem toboroz3 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- National Cancer Institute (NCI)13 vizsgálat
- Alliance for Clinical Trials in Oncology1 vizsgálat
- Children's Oncology Group1 vizsgálat
- ECOG-ACRIN Cancer Research Group1 vizsgálat
- Galera Therapeutics, Inc.1 vizsgálat
- és még 1
Lezárt vizsgálatok
Leállították
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC
NCT04476797· 1/2. fázis· Galera Therapeutics, Inc.· Forrás
Lezárult
Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer
NCT03602586· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03382561· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT03258554· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT03092674· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
NCT03204916· Children's Oncology Group· Forrás
Lezárult
Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma
NCT03033576· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
NCT02595905· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02498600· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
NCT02101788· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
NCT00861705· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás
Hibát jelzek